Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Orthofix Medical (OFIX) over the last 15 years, with Q4 2024 value amounting to $1.4 million.

  • Orthofix Medical's Treasury Shares fell 1250.0% to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year decrease of 1250.0%. This contributed to the annual value of $1.4 million for FY2024, which is 1250.0% down from last year.
  • According to the latest figures from Q4 2024, Orthofix Medical's Treasury Shares is $1.4 million, which was down 1250.0% from $1.6 million recorded in Q4 2023.
  • Over the past 5 years, Orthofix Medical's Treasury Shares peaked at $1.6 million during Q4 2023, and registered a low of $697495.0 during Q4 2020.
  • Over the past 5 years, Orthofix Medical's median Treasury Shares value was $1.4 million (recorded in 2022), while the average stood at $1.2 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first skyrocketed by 5961.7% in 2022, then plummeted by 1250.0% in 2024.
  • Over the past 5 years, Orthofix Medical's Treasury Shares (Quarter) stood at $697495.0 in 2020, then grew by 22.13% to $851847.0 in 2021, then skyrocketed by 59.62% to $1.4 million in 2022, then increased by 17.67% to $1.6 million in 2023, then fell by 12.5% to $1.4 million in 2024.
  • Its last three reported values are $1.4 million in Q4 2024, $1.6 million for Q4 2023, and $1.4 million during Q4 2022.